1. Home
  2. ELOX vs MCHX Comparison

ELOX vs MCHX Comparison

Compare ELOX & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eloxx Pharmaceuticals Inc. Common Stock

ELOX

Eloxx Pharmaceuticals Inc. Common Stock

N/A

Current Price

$13.20

Market Cap

60.3M

Sector

N/A

ML Signal

N/A

Logo Marchex Inc. Class B

MCHX

Marchex Inc. Class B

HOLD

Current Price

$1.31

Market Cap

60.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELOX
MCHX
Founded
1999
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
60.3M
60.3M
IPO Year
2013
2003

Fundamental Metrics

Financial Performance
Metric
ELOX
MCHX
Price
$13.20
$1.31
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $38.25
N/A
AVG Volume (30 Days)
17.7K
★ 26.7K
Earning Date
08-12-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 41.67
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $90,291,000.00
Revenue This Year
N/A
$17.69
Revenue Next Year
N/A
$29.82
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$10.00
$1.15
52 Week High
$23.40
$2.00

Technical Indicators

Market Signals
Indicator
ELOX
MCHX
Relative Strength Index (RSI) 40.05 42.39
Support Level $10.74 $1.20
Resistance Level $14.65 $1.46
Average True Range (ATR) 1.28 0.08
MACD -0.04 0.01
Stochastic Oscillator 21.89 25.00

Price Performance

Historical Comparison
ELOX
MCHX

About ELOX Eloxx Pharmaceuticals Inc. Common Stock

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

About MCHX Marchex Inc. Class B

Marchex Inc provides AI-based conversational intelligence and analytics solutions that generate insights from customer communications data. The company's products support sales, marketing, and executive teams in analyzing customer interactions across communication channels and informing business decisions. It serves companies operating in business-to-business-to-consumer (B2B2C) markets across multiple industries like automotive, home services, healthcare, real estate, and advertising. The company operates in a single segment: conversational analytics and related solutions. The company generates the majority of revenue from its conversational intelligence product offerings. Geographically, it generates the maximum revenue from the United States.

Share on Social Networks: